Roh M - Search Results

1

Gender Disparity in Referral for Definitive Care of Malignant Pleural Effusions.

Foote DC, Burke CR, Pandian B, Banks S, Haug KL, Hipp M, Zhao L, Smola B, Roh M, Carrott PW Jr, Lynch WR, Chang AC, Lin J, Reddy RM. Foote DC, et al. Among authors: roh m. J Surg Res. 2019 Dec;244:409-416. doi: 10.1016/j.jss.2019.06.068. Epub 2019 Jul 17. J Surg Res. 2019. PMID: 31325663

2

The impact of using the Bethesda System for reporting thyroid cytology diagnostic criteria on the follicular lesion of undetermined significance category.

Lee B, Smola B, Roh MH, Hughes DT, Miller BS, Jing X. Lee B, et al. J Am Soc Cytopathol. 2014 May-Jun;3(3):131-136. doi: 10.1016/j.jasc.2014.01.009. Epub 2014 Jan 28. J Am Soc Cytopathol. 2014. PMID: 31051736

3

Minimizing the diagnosis of "follicular lesion of undetermined significance" and identifying predictive features for neoplasia.

Jing X, Roh MH, Knoepp SM, Zhao L, Michael CW. Jing X, et al. Among authors: roh mh. Diagn Cytopathol. 2011 Oct;39(10):737-42. doi: 10.1002/dc.21459. Epub 2010 Oct 14. Diagn Cytopathol. 2011. PMID: 20949471 Free article.

4

Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.

Lew M, Pang JC, Roh MH, Jing X. Lew M, et al. Among authors: roh mh. Acta Cytol. 2015;59(5):412-7. doi: 10.1159/000441647. Epub 2015 Nov 21. Acta Cytol. 2015. PMID: 26587773

5

The application of immunocytochemistry to direct smears in the diagnosis of effusions.

Knoepp SM, Placido J, Fields KL, Thomas D, Roh MH. Knoepp SM, et al. Among authors: roh mh. Diagn Cytopathol. 2013 May;41(5):425-30. doi: 10.1002/dc.22852. Epub 2012 Apr 30. Diagn Cytopathol. 2013. PMID: 22549950 Free article.

6

Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.

Lew M, Pang JC, Jing X, Fields KL, Roh MH. Lew M, et al. Among authors: roh mh. Cancer Cytopathol. 2015 Oct;123(10):576-81. doi: 10.1002/cncy.21574. Cancer Cytopathol. 2015. PMID: 26465236 Free article.

7

Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.

El Hag M, Schmidt L, Roh M, Michael CW. El Hag M, et al. Among authors: roh m. Diagn Cytopathol. 2016 Apr;44(4):299-304. doi: 10.1002/dc.23442. Epub 2016 Jan 22. Diagn Cytopathol. 2016. PMID: 26799356

8

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

Cui TX, Kryczek I, Zhao L, Zhao E, Kuick R, Roh MH, Vatan L, Szeliga W, Mao Y, Thomas DG, Kotarski J, Tarkowski R, Wicha M, Cho K, Giordano T, Liu R, Zou W. Cui TX, et al. Among authors: roh mh. Immunity. 2013 Sep 19;39(3):611-21. doi: 10.1016/j.immuni.2013.08.025. Epub 2013 Sep 5. Immunity. 2013. PMID: 24012420 Free PMC article.

9

Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.

Wiseman W, Michael CW, Roh MH. Wiseman W, et al. Diagn Cytopathol. 2011 Sep;39(9):651-6. doi: 10.1002/dc.21442. Epub 2010 Oct 14. Diagn Cytopathol. 2011. PMID: 20949455 Free article.

10

Pathologic evaluation of explanted vaginal mesh: interdisciplinary experience from a referral center.

Smith TM, Smith SC, Delancey JO, Fenner DE, Schimpf MO, Roh MH, Morgan DM. Smith TM, et al. Among authors: roh mh. Female Pelvic Med Reconstr Surg. 2013 Jul-Aug;19(4):238-41. doi: 10.1097/SPV.0b013e31829996e2. Female Pelvic Med Reconstr Surg. 2013. PMID: 23797523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters